S&P 500   3,299.09 (+0.14%)
DOW   26,748.99 (+0.32%)
QQQ   269.32 (-0.02%)
AAPL   438.80 (+0.70%)
MSFT   211.89 (-2.15%)
FB   248.72 (-1.29%)
GOOGL   1,464.51 (-1.23%)
AMZN   3,110.27 (-0.05%)
NVDA   444.76 (+0.99%)
CGC   18.98 (-0.42%)
BABA   261.23 (+1.28%)
TSLA   1,466.49 (-1.25%)
MU   50.75 (+0.71%)
GE   6.15 (+0.65%)
AMD   84.78 (+9.15%)
T   29.97 (+1.18%)
F   6.76 (+1.05%)
ACB   10.53 (+1.06%)
GILD   70.61 (-1.56%)
NFLX   504.56 (+1.19%)
DIS   117.52 (+1.01%)
BAC   24.99 (+0.08%)
BA   165.94 (+2.26%)
S&P 500   3,299.09 (+0.14%)
DOW   26,748.99 (+0.32%)
QQQ   269.32 (-0.02%)
AAPL   438.80 (+0.70%)
MSFT   211.89 (-2.15%)
FB   248.72 (-1.29%)
GOOGL   1,464.51 (-1.23%)
AMZN   3,110.27 (-0.05%)
NVDA   444.76 (+0.99%)
CGC   18.98 (-0.42%)
BABA   261.23 (+1.28%)
TSLA   1,466.49 (-1.25%)
MU   50.75 (+0.71%)
GE   6.15 (+0.65%)
AMD   84.78 (+9.15%)
T   29.97 (+1.18%)
F   6.76 (+1.05%)
ACB   10.53 (+1.06%)
GILD   70.61 (-1.56%)
NFLX   504.56 (+1.19%)
DIS   117.52 (+1.01%)
BAC   24.99 (+0.08%)
BA   165.94 (+2.26%)
S&P 500   3,299.09 (+0.14%)
DOW   26,748.99 (+0.32%)
QQQ   269.32 (-0.02%)
AAPL   438.80 (+0.70%)
MSFT   211.89 (-2.15%)
FB   248.72 (-1.29%)
GOOGL   1,464.51 (-1.23%)
AMZN   3,110.27 (-0.05%)
NVDA   444.76 (+0.99%)
CGC   18.98 (-0.42%)
BABA   261.23 (+1.28%)
TSLA   1,466.49 (-1.25%)
MU   50.75 (+0.71%)
GE   6.15 (+0.65%)
AMD   84.78 (+9.15%)
T   29.97 (+1.18%)
F   6.76 (+1.05%)
ACB   10.53 (+1.06%)
GILD   70.61 (-1.56%)
NFLX   504.56 (+1.19%)
DIS   117.52 (+1.01%)
BAC   24.99 (+0.08%)
BA   165.94 (+2.26%)
S&P 500   3,299.09 (+0.14%)
DOW   26,748.99 (+0.32%)
QQQ   269.32 (-0.02%)
AAPL   438.80 (+0.70%)
MSFT   211.89 (-2.15%)
FB   248.72 (-1.29%)
GOOGL   1,464.51 (-1.23%)
AMZN   3,110.27 (-0.05%)
NVDA   444.76 (+0.99%)
CGC   18.98 (-0.42%)
BABA   261.23 (+1.28%)
TSLA   1,466.49 (-1.25%)
MU   50.75 (+0.71%)
GE   6.15 (+0.65%)
AMD   84.78 (+9.15%)
T   29.97 (+1.18%)
F   6.76 (+1.05%)
ACB   10.53 (+1.06%)
GILD   70.61 (-1.56%)
NFLX   504.56 (+1.19%)
DIS   117.52 (+1.01%)
BAC   24.99 (+0.08%)
BA   165.94 (+2.26%)
Log in

NASDAQ:RIGLRigel Pharmaceuticals News Headlines

$2.38
-0.05 (-2.06 %)
(As of 08/4/2020 01:34 PM ET)
Add
Compare
Today's Range
$2.34
Now: $2.38
$2.48
50-Day Range
$1.78
MA: $2.25
$4.13
52-Week Range
$1.23
Now: $2.38
$5.24
Volume86,491 shs
Average Volume19.39 million shs
Market Capitalization$401.20 million
P/E RatioN/A
Dividend YieldN/A
Beta1.35

Headlines

Rigel Pharmaceuticals (NASDAQ RIGL) News Headlines

Source:
DateHeadline
Rigel Pharmaceuticals (NASDAQ:RIGL) Upgraded to Hold at Zacks Investment ResearchRigel Pharmaceuticals (NASDAQ:RIGL) Upgraded to Hold at Zacks Investment Research
marketbeat.com - July 29 at 9:19 AM
Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Up 5.7%Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Up 5.7%
americanbankingnews.com - August 3 at 9:08 PM
Rigel Pharmaceuticals (NASDAQ:RIGL)  Shares Down 6.4% Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Down 6.4%
www.americanbankingnews.com - July 29 at 9:22 PM
Rigel Pharmaceuticals (RIGL) Set to Announce Quarterly Earnings on TuesdayRigel Pharmaceuticals (RIGL) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - July 29 at 11:19 AM
Earnings Preview: Rigel Pharmaceuticals (RIGL) Q2 Earnings Expected to DeclineEarnings Preview: Rigel Pharmaceuticals (RIGL) Q2 Earnings Expected to Decline
finance.yahoo.com - July 28 at 1:19 PM
Why Rigel Pharmaceuticals Is Moving TodayWhy Rigel Pharmaceuticals Is Moving Today
finance.yahoo.com - July 27 at 7:42 PM
Rigel Announces Post-hoc Data Analysis of TAVALISSE® in Adult Patients with Immune Thrombocytopenia Published in the British Journal of HaematologyRigel Announces Post-hoc Data Analysis of TAVALISSE® in Adult Patients with Immune Thrombocytopenia Published in the British Journal of Haematology
finance.yahoo.com - July 27 at 9:41 AM
Rigel: Fostamatinib Joins The COVID-19 Campaign And Resuscitates My Bullish OutlookRigel: Fostamatinib Joins The COVID-19 Campaign And Resuscitates My Bullish Outlook
seekingalpha.com - July 23 at 6:41 PM
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Down to $2.73Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Down to $2.73
www.americanbankingnews.com - July 23 at 2:51 PM
Analysts Offer Predictions for Rigel Pharmaceuticals, Inc.s FY2022 Earnings (NASDAQ:RIGL)Analysts Offer Predictions for Rigel Pharmaceuticals, Inc.'s FY2022 Earnings (NASDAQ:RIGL)
www.americanbankingnews.com - July 23 at 9:43 AM
Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Down 3.8%Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Down 3.8%
www.americanbankingnews.com - July 22 at 4:33 PM
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Rating of "Hold" from AnalystsRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - July 22 at 10:31 AM
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Expected to Post Quarterly Sales of $14.28 MillionRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Expected to Post Quarterly Sales of $14.28 Million
www.americanbankingnews.com - July 15 at 11:37 PM
Stock Alert: Rigel Pharma Soars 80%Stock Alert: Rigel Pharma Soars 80%
www.nasdaq.com - July 14 at 1:57 PM
Rigel Pharma to Test Potential Drug for Covid-19 PneumoniaRigel Pharma to Test Potential Drug for Covid-19 Pneumonia
finance.yahoo.com - July 14 at 1:57 PM
Mid-Day Market Update: Dow Rises 1%; Rigel Pharmaceuticals Shares Spike HigherMid-Day Market Update: Dow Rises 1%; Rigel Pharmaceuticals Shares Spike Higher
feeds.benzinga.com - July 14 at 12:30 PM
Rigels stock jumps 25% after announcing U.K. trial for possible COVID-19 treatmentRigel's stock jumps 25% after announcing U.K. trial for possible COVID-19 treatment
www.msn.com - July 14 at 8:56 AM
Rigel launches fostamatinib trial in patients with COVID-19 pneumoniaRigel launches fostamatinib trial in patients with COVID-19 pneumonia
seekingalpha.com - July 14 at 8:56 AM
Rigel Announces Investigator-Sponsored Trial of Fostamatinib in Patients with COVID-19 PneumoniaRigel Announces Investigator-Sponsored Trial of Fostamatinib in Patients with COVID-19 Pneumonia
finance.yahoo.com - July 14 at 8:56 AM
Rigel's stock jumps 25% after announcing U.K. trial for possible COVID-19 treatmentRigel's stock jumps 25% after announcing U.K. trial for possible COVID-19 treatment
finance.yahoo.com - July 14 at 8:56 AM
Traders Buy High Volume of Rigel Pharmaceuticals Call Options (NASDAQ:RIGL)Traders Buy High Volume of Rigel Pharmaceuticals Call Options (NASDAQ:RIGL)
www.americanbankingnews.com - July 13 at 12:36 PM
-$0.13 Earnings Per Share Expected for Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) This Quarter-$0.13 Earnings Per Share Expected for Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) This Quarter
www.americanbankingnews.com - July 13 at 3:16 AM
Rigel Pharmaceuticals (NASDAQ:RIGL) Receives "Buy" Rating from HC WainwrightRigel Pharmaceuticals (NASDAQ:RIGL) Receives "Buy" Rating from HC Wainwright
www.americanbankingnews.com - July 10 at 7:05 AM
Rigel Announces Availability of TAVLESSE® (Fostamatinib Disodium Hexahydrate) in EuropeRigel Announces Availability of TAVLESSE® (Fostamatinib Disodium Hexahydrate) in Europe
finance.yahoo.com - July 9 at 8:43 AM
Is Rigel Pharmaceuticals, Inc. (RIGL) Going to Burn These Hedge Funds?Is Rigel Pharmaceuticals, Inc. (RIGL) Going to Burn These Hedge Funds?
finance.yahoo.com - June 27 at 11:03 PM
Rigel to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual ConferenceRigel to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference
finance.yahoo.com - June 17 at 9:59 AM
Rigel to Present Poster Highlighting TAVALISSE at the Virtual Edition of the 25th European Hematology Association (EHA) Annual CongressRigel to Present Poster Highlighting TAVALISSE at the Virtual Edition of the 25th European Hematology Association (EHA) Annual Congress
finance.yahoo.com - June 11 at 9:35 AM
Rigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-CongressRigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-Congress
finance.yahoo.com - June 3 at 8:14 AM
Rigel Pharmaceuticals Remains Undervalued Despite Slowdown In Q1 Tavalisse SalesRigel Pharmaceuticals Remains Undervalued Despite Slowdown In Q1 Tavalisse Sales
seekingalpha.com - May 12 at 11:46 PM
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Just Reported And Analysts Have Been Cutting Their EstimatesRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Just Reported And Analysts Have Been Cutting Their Estimates
finance.yahoo.com - May 8 at 5:14 PM
Edited Transcript of RIGL earnings conference call or presentation 5-May-20 8:30pm GMTEdited Transcript of RIGL earnings conference call or presentation 5-May-20 8:30pm GMT
finance.yahoo.com - May 6 at 1:02 PM
Rigel Pharmaceuticals Inc (RIGL) Q1 2020 Earnings Call TranscriptRigel Pharmaceuticals Inc (RIGL) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 6 at 1:02 PM
EARNINGS SUMMARY: Details of Rigel Pharmaceuticals Inc. Q1 Earnings ReportEARNINGS SUMMARY: Details of Rigel Pharmaceuticals Inc. Q1 Earnings Report
www.nasdaq.com - May 5 at 11:10 PM
Rigel Pharmaceuticals (RIGL) Q1 Earnings Match EstimatesRigel Pharmaceuticals (RIGL) Q1 Earnings Match Estimates
finance.yahoo.com - May 5 at 11:10 PM
Rigel Pharmaceuticals EPS in-line, misses on revenueRigel Pharmaceuticals EPS in-line, misses on revenue
seekingalpha.com - May 5 at 4:21 PM
Rigel Reports First Quarter 2020 Financial Results and Provides Business UpdateRigel Reports First Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - May 5 at 4:21 PM
Rigel Announces Change to Virtual Format for 2020 Annual Meeting of StockholdersRigel Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
finance.yahoo.com - May 1 at 7:09 PM
Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseRigel Pharmaceuticals (RIGL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
finance.yahoo.com - April 28 at 6:10 PM
Rigel Announces Conference Call and Webcast to Report First Quarter 2020 Financial Results and Business UpdateRigel Announces Conference Call and Webcast to Report First Quarter 2020 Financial Results and Business Update
finance.yahoo.com - April 27 at 7:48 AM
Imagine Owning Rigel Pharmaceuticals (NASDAQ:RIGL) While The Price Tanked 57%Imagine Owning Rigel Pharmaceuticals (NASDAQ:RIGL) While The Price Tanked 57%
finance.yahoo.com - April 11 at 2:00 PM
Edited Transcript of RIGL earnings conference call or presentation 27-Feb-20 9:30pm GMTEdited Transcript of RIGL earnings conference call or presentation 27-Feb-20 9:30pm GMT
finance.yahoo.com - March 21 at 6:27 PM
Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) A Volatile Stock?Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) A Volatile Stock?
finance.yahoo.com - March 12 at 12:41 PM
Rigel Pharmaceuticals Continues To Grow While The Stock Remains SubduedRigel Pharmaceuticals Continues To Grow While The Stock Remains Subdued
seekingalpha.com - March 3 at 2:13 PM
Rigel Pharmaceuticals, Inc. 2019 Q4 - Results - Earnings Call PresentationRigel Pharmaceuticals, Inc. 2019 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 27 at 9:55 PM
Rigel: 4Q Earnings SnapshotRigel: 4Q Earnings Snapshot
finance.yahoo.com - February 27 at 7:23 PM
Rigel Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business UpdateRigel Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
www.prnewswire.com - February 27 at 7:23 PM
Rigel Pharmaceuticals (RIGL) Reports Q4 Loss, Misses Revenue EstimatesRigel Pharmaceuticals (RIGL) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - February 27 at 7:23 PM
Earnings Preview: Rigel Pharmaceuticals (RIGL) Q4 Earnings Expected to DeclineEarnings Preview: Rigel Pharmaceuticals (RIGL) Q4 Earnings Expected to Decline
finance.yahoo.com - February 20 at 2:32 PM
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Is Breakeven Near?Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Is Breakeven Near?
finance.yahoo.com - February 11 at 3:01 PM
Rigel Pharmaceuticals: Tavalisse Makes Inroads In Lucrative ITP Market, Additional Value Drivers In PlayRigel Pharmaceuticals: Tavalisse Makes Inroads In Lucrative ITP Market, Additional Value Drivers In Play
seekingalpha.com - February 4 at 6:38 PM
Rigel Pharmaceuticals, Inc. Common Stock (RIGL) Revenue EPSRigel Pharmaceuticals, Inc. Common Stock (RIGL) Revenue EPS
www.nasdaq.com - January 29 at 7:41 PM
This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.